Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care
ConclusionA patient-tailored CIM program, initiated within a week of the first chemotherapy cycle, may help reduce the severity of fatigue, depression, and impaired well-being among patients with breast and gynecological cancers.
This study examined the prevalence of hypogonadism, its clinical and genetic risk factors, and its relationship to adverse health outcomes (AHOs) in North American testicular cancer survivors (TCS) after modern platinum-based chemotherapy. PATIENTS AND METHODS: Eligible TCS were
CONCLUSION: Within the Canadian context, the built environment is associated with a range of chronic health conditions and injury in adults, but the evidence to date has limitations. More research on the built environment and health incorporating rigorous study designs are needed to provide stronger causal evidence to inform policy and practice. PMID: 31091062 [PubMed - in process]
Conclusion: QoL of lung cancer patients is associated with anxiety/depression and other factors that can be modified by specific interventions. It is therefore possible to take care of psychological aspects to improve the QoL of Vietnamese people suffering from this condition.
Conclusions: This study shows for the first time that a specific form of Tibetan medicine meditation is efficacious in decreasing the psychological distress in women with breast cancer and can be an important complementary therapy to oncological care.Oncology
Abstract BACKGROUND: Breast cancer is one of the most common tumors in the world and is associated with high psychological distress such as depression, anxiety, and stress. Meditation is efficacious to reduce psychological distress, but there are no studies which have evaluated a specific type of Tibetan medicine meditation in patients with breast cancer. The present research aimed to understand the effect a specific type of Tibetan medicine meditation on psychological distress in a sample of women with breast cancer. METHODS: Sixty-two women with breast cancer were enrolled. We instructed the patients in Tib...
Background: While CBGT has been found effective in treating VMS for women with breast cancer (MENOS1), CBGT has not been studied comparing outcomes among women of differing race and psychiatric diagnoses. This preliminary study evaluated effects of a CBGT treatment developed by Hunter&Smith (2015) on primary outcomes of hot flash frequency and problem rating (HFF-PR), hot flash daily interference (HFDIS) and quality of life (QOL). Secondary outcomes included depression, anxiety, perceived stress (PS), anhedonia, and hot flash beliefs (HFBS).
Long-term AIDS Survivors (LTAS) are people with HIV diagnosed prior to the advent of antiretroviral therapy. LTAS suffer high rates of multiple psychiatric illnesses; demoralization is a syndrome common in LTAS and is characterized by a sense of helplessness, hopelessness, and a loss of meaning and purpose in life. Psilocybin is a 5HT2A agonist and classic psychedelic that can improve depression and anxiety in cancer patients when combined with individual psychotherapy, possibly by decreasing demoralization.
CONCLUSION: The prevalence of anxiety and depression in our patients was slightly higher than those reported in the literature. The main factors correlated with the onset of depression and anxiety were: severe pain, bone location, and advanced stage of the disease. PMID: 31097369 [PubMed - as supplied by publisher]
Prevention is often called the best medicine — but research has shown that millions of Americans are not getting the preventive care they should to live long, healthy lives. Obstacles like inadequate access to care and financial barriers can keep people away from the doctor, but anxiety and feeling like care is unnecessary are also common deterrents. “There are a lot of things that every person could do to stay healthy, and this could help people to feel better, improve their quality of life and help them to live longer,” says Dr. Alex Krist, a professor of family medicine at Virginia Commonwealth Univer...
AbstractDisruptions in growth hormone/insulin-like growth factor-1 (GH/IGF-1) signaling have been linked to improved longevity in mice and humans. Nevertheless, while IGF-1 levels are associated with increased cancer risk, they have been paradoxically implicated with protection from other age-related conditions, particularly in the brain, suggesting that strategies aimed at selectively increasing central IGF-1 action may have favorable effects on aging. To test this hypothesis, we generated inducible, brain-specific (TRE-IGF-1 × Camk2a-tTA) IGF-1 (bIGF-1) overexpression mice and studied effects on healthspan. Doxycyc...